Illumina (MIL:1ILMN) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


MIL:1ILMN Illumina Inc MIL:1ILMN
49 GF Score
Price €143.82
GF Value €104.58
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Illumina's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

MIL:1ILMN vs MTD, DGX, LH: Margin of Safety % (DCF FCF Based) Comparison

For the Diagnostics & Research subindustry, Illumina's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Illumina Margin of Safety % (DCF FCF Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Illumina's Margin of Safety % (DCF FCF Based) falls into.


MIL:1ILMN
49GF Score
Illumina Inc MIL:1ILMN
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Illumina (MIL:1ILMN) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of €143.82 is trading 37.5% above its estimated GF Value™ of €104.58. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for MIL:1ILMN:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €104.58 vs. price of €143.82 (37.5% above fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the MIL:1ILMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
49GF Score

Get the complete analysis for MIL:1ILMN

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.82
Price
€104.58
GF Value